Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. (FENC) Stock Overview
Explore Fennec Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
216.5M
P/E Ratio
-15.45
EPS (TTM)
$-0.53
ROE
5.90%
FENC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Fennec Pharmaceuticals Inc. (FENC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 37.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.27.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.45 and a market capitalization of 216.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.